Tonix Pharmaceuticals Holding (TNXP) Change in Acquisitions & Divestments (2016)

Tonix Pharmaceuticals Holding (TNXP) posted quarterly Change in Acquisitions & Divestments of $4.8 million for Q1 2016.

Tonix Pharmaceuticals Holding (TNXP) Change in Acquisitions & Divestments (2016) Analysis & Trends

Tonix Pharmaceuticals Holding's Change in Acquisitions & Divestments history runs 1 years deep, the most recent figure standing at $4.8 million for Q1 2016.

  • In Q1 2016, Change in Acquisitions & Divestments changed N/A year-over-year to $4.8 million; the TTM figure through Dec 2017 stood at $4.8 million (changed N/A YoY), while the FY2025 annual figure was $853000.0, changed N/A from the prior year.
  • Change in Acquisitions & Divestments for Q1 2016 stood at $4.8 million.
  • The five-year high for Change in Acquisitions & Divestments was $4.8 million in Q1 2016, with the low at $4.8 million in Q1 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Tonix Pharmaceuticals Holding 213.43 Mn 213.43 Mn 12.84 Mn

Historic Data

Download Data
DateValue
Mar 31, 2016 4.78 Mn
Mar 31, 2016 4.78 Mn